Rare diseases
Investigational molecules
Locations
Back to France1 clinical trial in Barbâtre, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on Type 2 diabetes patients without prior cardiovascular events, exploring preventive strategies for heart-related complications.
The study evaluates combination therapy approaches using colchicine and aspirin to improve cardiovascular outcomes in high-risk diabetic patients. This research aims to establish new preventive strategies for reducing serious cardiovascular events in the diabetic population.
Investigation of novel therapeutic combinations for preventing cardiovascular complications in diabetes patients, focusing on established medications in new applications.
The research explores the potential benefits of dual-agent therapy in preventing major adverse cardiac events, specifically targeting patients before the onset of cardiovascular disease.
Comprehensive study of cardiovascular prevention strategies in diabetic patients, evaluating interventions to reduce the risk of serious cardiac events.
This research initiative focuses on identifying effective preventive measures against various cardiovascular outcomes, including cardiac arrest, myocardial infarction, and stroke in the diabetic population.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
